Login to Your Account

U.S. Biopharma Firms Hit by Cyber Attacks from China

By Shannon Ellis
Contributing Writer

Wednesday, June 12, 2013
SHANGHAI, China – While the presidents from the U.S. and China have met in a summit to address human rights and cyber-attack issues, it's become clear that U.S. biopharmaceutical firms have not been immune to targeted hacking out of China. These efforts may have yielded valuable data from clinical trials or drug registration applications.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription